Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting
NCT01986062
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
97
Enrollment
INDUSTRY
Sponsor class
Conditions
Attention Deficit Hyperactivity Disorder (ADHD)
Interventions
DRUG:
AR11
DRUG:
Placebo
Sponsor
Arbor Pharmaceuticals, Inc.